企業概要
HealthEquity, Inc. is a prominent entity within the healthcare sector, specifically operating in the health information services industry by providing technology-enabled services platforms to consumers and employers across the United States. These platforms facilitate the management of health savings accounts (HAS), offer investment services, and deliver online-only automated investment advisory tools through its Advisor platform. The company currently maintains a market capitalization of $7.19B, supported by an annual revenue of $1.31B and a workforce comprising 2,814 employees. These financial metrics indicate that HealthEquity, Inc. has established itself as a significant player in the digital health infrastructure space, reflecting substantial market penetration and operational scale within the specialized health information services domain.
財務健全性
The company's financial performance is characterized by a trailing twelve-month revenue of $1.31B and a net income of $215.20M, while EBITDA stands at $482.14M. The significant gap between the EBITDA figure and the net income reveals a cost structure where interest expenses, taxes, and amortization of intangible assets absorb a considerable portion of the operating earnings, which is typical for firms with substantial debt loads. Free cash flow for the period is reported at $338.05M, indicating a robust ability to generate cash from operations that exceeds capital expenditure requirements, thereby providing the company with significant financial flexibility for potential strategic initiatives or debt reduction. The profitability analysis highlights a gross margin of 69.5%, an operating margin of 21.6%, and a profit margin of 16.4%, suggesting that while the business model retains high value from its core services, significant operating costs and other expenses compress the bottom-line profitability. On the balance sheet, the company holds $318.93M in cash against total debt of $1.00B, resulting in a debt-to-equity ratio of 47.53%, which characterizes a moderately leveraged position where debt levels are substantial relative to equity but do not immediately threaten solvency. Liquidity is supported by a current ratio of 3.27, signaling a strong capacity to meet short-term obligations with current assets. Furthermore, the return on equity is 10.2% and the return on assets is 6.0%, metrics that demonstrate management's effectiveness in utilizing shareholder equity and total assets to generate profitable returns relative to the industry average for capitalized firms.
バリュエーション評価
Valuation metrics present a distinct dichotomy between current profitability and future expectations, with a trailing P/E ratio of 34.23 and a forward P/E of 15.76. This substantial disparity implies that the market anticipates a dramatic acceleration in earnings growth or a significant improvement in profit margins that will bring the forward valuation in line with historical trailing multiples. The price-to-book ratio is 3.40, indicating that the stock trades at a significant premium over its tangible book value, likely reflecting the intangible value of its proprietary technology and service platforms. Alternative valuation measures such as the price-to-sales ratio of 5.48 and an EV/EBITDA of 16.17 suggest that the company is priced for high growth, requiring consistent expansion to justify these multiples. Regarding trading range, the 52-week high is $116.65 and the 52-week low is $72.76, placing the current trading price in a context where the stock has experienced notable volatility over the past year. The beta value of 0.26 indicates that the stock exhibits very low price volatility relative to the broader market, behaving more as a defensive asset that is less sensitive to general equity market movements.
Growth & Income
The company demonstrates a revenue growth rate of 7.3% year-over-year and an earnings growth rate of 92.4% year-over-year. The fact that earnings are growing at a rate significantly faster than revenue implies substantial leverage in the income statement, where small increases in revenue are magnified into disproportionately large increases in net income, likely due to fixed cost structures or favorable margin expansion. As the company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it follows a capital allocation strategy of reinvesting all net income back into the business for growth rather than distributing cash to shareholders. This approach suggests that management prioritizes internal expansion and technology development over immediate shareholder returns via dividends. Overall, the growth and income profile of HealthEquity, Inc. is defined by aggressive earnings expansion driven by operational efficiency rather than dividend income, creating a value proposition centered on capital appreciation potential.